Manuel Mayr

Lung Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

99h-index33.5kcitations543works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(73), Advanced Proteomics Techniques and Applications(57), Cancer-related molecular mechanisms research(48), Metabolomics and Mass Spectrometry Studies(45), Atherosclerosis and Cardiovascular Diseases(43)

Publications540 total

Clinical proteomics in cardiovascular medicine: Current capabilities, limitations, and future directions
Atherosclerosis·2026Open Access
Anti‐Malondialdehyde Low‐Density Lipoprotein Antibodies and Valvular Calcification: A Substudy of the SCOT‐HEART Trial
Journal of the American Heart Association·2025Open Access
A genetic map of human metabolism across the allele frequency spectrum
Nature Genetics·2025· 1 citedOpen Access
Precision medicine requires precision proteomics: discordance between proteomic and clinical assays in UK Biobank
Cardiovascular Research·2025· 1 citedOpen Access
Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study
European Heart Journal·2025· 3 citedOpen Access
Intake of high-intensity statin after acute myocardial infarction assessed by direct drug concentration measurement: association with LDL-C response and coronary plaque modifications in the PACMAN-AMI trial
European Journal of Preventive Cardiology·2025· 1 citedOpen Access
Lipoprotein(a) is an apoe-containing particle enriched in triglyceride species associated with incident cardiovascular disease
Atherosclerosis·2025Open Access
Platelets and inflammation - Insights from platelet non-coding RNA content and release in the bruneck study and the PACMAN-AMI trial
Atherosclerosis·2025Open Access
Beyond LDL-C: Integrative proteomics and lipidomics analysis in PACMAN-AMI
Atherosclerosis·2025Open Access
Proteomics highlights the role of hyalectan remodelling in calcific aortic valve disease
Atherosclerosis·2025Open Access
SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2
EMBO Molecular Medicine·2025· 2 citedOpen Access
Proteomic risk scores for predicting common diseases using linear and neural network models in the UK biobank
Scientific Reports·2025· 3 citedOpen Access
A Comparative Proteomics Study of Autopsy and Fresh-Frozen Coronary Artery Samples
Journal of Proteome Research·2025· 4 citedOpen Access
Platelets and inflammation—insights from platelet non-coding RNA content and release in the Bruneck study and the PACMAN-AMI trial
Cardiovascular Research·2025· 3 citedOpen Access
Cardiac regeneration beyond stem cells: harnessing sarcomere dynamics and endogenous repair mechanisms
Cardiovascular Research·2025Open Access
Proteomic profiling reveals a higher presence of glycolytic enzymes in human atherosclerotic lesions with unfavourable histological characteristics
Cardiovascular Research·2025· 8 citedOpen Access
On the utility of immobilized phenylarsine oxide in the study of redox sensitive cardiac proteins
Scientific Reports·2025Open Access
Proteomic Profiling of Age-Related Proteins Following Extracorporeal Apheresis
Hormone and Metabolic Research·2025· 3 cited
Female-biased vascular smooth muscle cell gene regulatory networks predict MYH9 as a key regulator of fibrous plaque phenotype
2025Open Access
Transcriptional Atlas of Cardiac Disease
2025Open Access
page 1 of 27Next →

Frequent Co-authors

Stefan Kiechl(18), Qingbo Xu(17), Johann Willeit(15), Xiaoke Yin(14), Peter Willeit(12), Anna Zampetaki(7), Ignat Drozdov(7), Ursula Mayr(6), Friedrich Oberhollenzer(5), Thomas Thum(5), Marianna Prokopi(4), Agnes Mayr(4), Ajay M. Shah(4), Raimund Pechlaner(4), Sarah R. Langley(4), Peter Santer(4), Georg Wick(4), Temo Barwari(4), Athanasios Didangelos(4), Yanhua Hu(4)